Tavilermide (MIM-D3)

MIM-D3 · Mimetogen Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tavilermide (MIM-D3), covering 2019-08-16 to 2019-08-16. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]